Efavirenz.
Porche
D J
DJ
Louisiana State University Health Sciences Center School of Nursing, USA.
D000480:Alkynes; D048588:Benzoxazines; D001682:Biological Availability; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism / Q000451:nursing; D006801:Humans; D007408:Intestinal Absorption; D009730:Nursing Assessment; D010078:Oxazines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz